comparemela.com

Latest Breaking News On - Vp business development at can - Page 1 : comparemela.com

Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference Seite 1

11.03.2024 - Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business Development, Dr. Sari . Seite 1

Sari fishmanVp business development at canBio europe conferenceNamodenoson treatment for pancreatic and liver cancer

Namodenoson Treatment for Pancreatic and Liver Cancer: Data will be Discussed in Out-licensing and Distribution Partnering Meetings at Bio Europe Conference -March 11, 2024 at 07:06 am EDT

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced its VP of Business.

South koreaComunidad autonoma de catalunaUnited statesGebro pharmaSari fishmanDrug administrationVp business development at canBusiness developmentFite biopharma ltdCan fite biopharmaEurope springBio europe conferenceFite biopharmaOrphan drug designationFast track designationAnnual report

vimarsana © 2020. All Rights Reserved.